US 11851653
Materials and methods for treatment of alpha-1 antitrypsin deficiency
granted A61KA61K31/7088A61K48/00
Quick answer
US patent 11851653 (Materials and methods for treatment of alpha-1 antitrypsin deficiency) held by CRISPR THERAPEUTICS AG expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/7088, A61K48/00, A61K9/0019, A61P